Sahpra warns against counterfeit GLP-1 products like Ozempic, citing health risks. Only registered products should be used; ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

Sahpra warns of falsified diabetes treatments Ozempic and Mounjaro sold online for weight loss, posing health risks.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

It’s known as a GIP/GLP-1 receptor agonist. In simpler terms, this medication targets two receptors in the body, whereas ...

A 7-mg and 14-mg dose of oral semaglutide is currently approved for type 2 diabetes under the name Rybelsus. "The ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...